Skip to main content

Peer Review reports

From: Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity

Original Submission
14 Nov 2023 Submitted Original manuscript
15 Nov 2023 Author responded Author comments - Kok Lim Kua
15 Nov 2023 Author responded Author comments - Kok Lim Kua
Resubmission - Version 2
15 Nov 2023 Submitted Manuscript version 2
29 Feb 2024 Reviewed Reviewer Report - C. Armitage Harper
8 Mar 2024 Reviewed Reviewer Report
30 Apr 2024 Author responded Author comments - Kok Lim Kua
Resubmission - Version 3
30 Apr 2024 Submitted Manuscript version 3
8 May 2024 Reviewed Reviewer Report - C. Armitage Harper
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 May 2024 Editorially accepted
24 May 2024 Article published 10.1186/s12886-024-03483-w

You can find further information about peer review here.

Back to article page